ChangeNOW CSO Pauline Shangett digs into the infrastructure underpinning the exchange’s simple, streamlined frontend.

Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced financial results for the fiscal fourth ...

A former Arby’s manager in Oklahoma has been arrested after she allegedly infected a customer and her family with oral herpes ...

A former Arby's manager in Oklahoma is facing criminal charges and a civil lawsuit after allegedly spitting into a customer's ...

MEXC Futures M-Day is a promotional futures event in which customers trade USDT-M or Coin-M futures for a chance to win ...

Replimune Group, Inc. nears a pivotal FDA AdCom for RP1 ahead of an Aug 2, 2026 decision. Click for this REPLY stock update ...

An Oklahoma woman sues Arby's after allegedly contracting herpes from a contaminated sandwich. The lawsuit follows a ...

One of the most recurring issues in construction contracts, typically in public-works contracts, is the validity of ‘no-claim ...

Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, announced today that the U.S. Food and Drug Administration ...

Down 32% from all-time highs, TerraVest is a TSX dividend stock that offers you significant upside potential in June 2026.

Scavenge for gold, coins, and other buried treasure with these metal detectors, including models from Nokta and Minelab.

If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...